Insulin therapy induced adiposity evaluated by computed tomography is not visceral

Pakistan Journal of Medical Sciences

Volumn 23, Issue 2, 2007, Pages 161-166

  Elsayed, Ahmed ^a   ElGebely, Soliman ^b   Galal, Ahmed ^c  

^a AL AMIRI HOSPITAL   (Kuwait)

^b MUBARAK AL KABEER HOSPITAL   (Kuwait)

^c MANSOURA UNIVERSITY   (Egypt)

Author keywords

Adiposity; Computed tomography; Fat distribution; Insulin therapy; Type 2 diabetes; Visceral fat

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ABDOMINAL RADIOGRAPHY; ABDOMINAL SUBCUTANEOUS FAT; ADULT; ARTICLE; ATHEROSCLEROSIS; BODY FAT DISTRIBUTION; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC PATIENT; DRUG SAFETY; HEMOGLOBIN DETERMINATION; HUMAN; INSULIN TREATMENT; INTRAABDOMINAL FAT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; TREATMENT OUTCOME; WAIST CIRCUMFERENCE;

EID: 34249653125     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Heller S. Weight gain during insulin therapy in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2004;65 Suppl 1:S23-7.
2. Larger E, Rufat P, Dubois-Laforgue D, Ledoux S. Insulin and weight gain: myth or reality?]Diabetes Metab 2001;27:S23-7.
3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352(9131):837-53.
4. Despres JP, Lemieux I, Prud'homme D. Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ 2001;322:716-20.
5. Fujimoto WY, Bergstrom RW, Boyko EJ, Chen KW, Leonetti DL, Newell-Morris L, et al. Visceral adiposity and incident coronary heart disease in Japanese-American men: the 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care 1999;22:1808-12.
6. Rexrode K, Carey V, Hennekens C, Walters E, Colditz G, Stampfer M, et al. Abdominal adiposity and coronary heart disease in women. JAMA 1998;280:1843-48.
7. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: A 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed) 1984;289:1257-61.
8. Lemieux S: Contribution of visceral obesity to the insulin resistance syndrome. Can J Appl Physiol 2001;26:273-90.
9. Brochu M, Starling RD, Tchernof A, Matthews DE, Garcia-Rubi E, Poehlman ET. Visceral adipose tissue is an independent correlate of glucose disposal in older obese postmenopausal women. J Clin Endocrinol Metab 2000;85:2378-84.
10. Carey D, Jenkins A, Campbell L, Freund J, Chisholm D. Abdominal fat and insulin resistance in normal and overweight women-direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 1996;45:633-8.
11. Ross R, Fortier L, Hudson R. Separate associations between visceral and subcutaneous adipose tissue distribution, insulin and glucose levels in obese women. Diabetes Care 1996;19:1404-11.
12. Despres J, Nadeau A, Tremblay A, Ferland M, Moorjani S, Lupien P, et al. Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes 1989;38:304-9.
13. DeNino WF, Tchernof A, Dionne IJ, Toth MJ, Ades PA, Sites CK, et al. Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care 2001;24:925-32.
14. DiPietro L, Katz L, Nadel E. Excess abdominal adiposity remains correlated with altered lipid concentrations in healthy older women. Int J Obes Relat Metab Disord 1999;23(4):432-6.
15. Park KS, Rhee BD, Lee KU, Kim SY, Lee HK, Koh CS, et al. Intra-abdominal fat is associated with decreased insulin sensitivity in healthy young men. Metabolism 1991;(6):40:600-3.
16. Sinha A, Formica C, Tsalamandris C, Panagiotopoulos S, Hendrich E, DeLuise M, et al. Effects of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes. Diabet Med 1996;13: 40-6.
17. Mäkimattila S, Nikkilä K, Yki-Järvinen H. Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus. Diabetologia 1999;42(4):406-12.
18. Bonora E. The metabolic syndrome and cardiovascular disease. Ann Med 2006;38(1):64-80.
19. The Diabetes Control and Complications Trial Research Group. Influence of intensive diabetes treatment on body weight and composition of adults with type 1 diabetes in the Diabetes Control and Complications Trial. Diabetes Care 2001;24:1711-21.
20. Enzi G, Gasparo M, Biondetti P, Fiore D, Semisa M, Zurlo F. Subcutaneous and visceral fat distribution according to sex, age and overweight, evaluated by computed tomography. Am J Clin Nutr 1986;44(6):739-46 .
21. Lemieux S, Prud'homme D, Bouchard C, Tremblay A, Despres J. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am J Clin Nutr 1993;58(4):463-67.
22. Ter Maaten JC, Serne EH, Van Eps WS, Ter Wee PM, Donker AJ, Gans RO. Effects of insulin and atrial natriuretic peptide on renal tubular sodium handling in sickle cell disease. Am J Physiol Renal Physiol 2000;278(3):F499- 505.
23. Ter Maaten JC, Bakker SJ, Serne EH, ter Wee PM, Donker AJ, Gans RO. Insulin's acute effects on glomerular filtration rate correlate with insulin sensitivity whereas insulin's acute effects on proximal tubular sodium reabsorption correlation with salt sensitivity in normal subjects. Nephrol Dial Transplant 1999;14(10):2357-63.
24. Bagg W, Plank LD, Gamble G, Drury PL, Sharpe N, Braatvedt GD. The effects of intensive glycaemic control on body composition in patients with type 2 diabetes. Diabetes Obes Metab 2001;3(6):410-16.
25. Takei I, Takayama S, Yamauchi A, Nakamoto S, Kitamura Y, Katsukawa F, et al. Effect of insulin therapy on body fat distribution in NIDDM patients with secondary sulfonylurea failure: a preliminary report. Eur J Clin Nutr 1998;52(2):153-4.
26. Yki-Jarvinen H, Ryysy L, Kauppila M, Kujansuu E, Lahti J, Marjanen T, et al. Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997;82(12):4037-43.
27. Purnell JQ, Hokanson JE, Marcovina SM, Steffes MW, Cleary PA, Brunzell JD. Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial. JAMA 1998;280(2):140-6.